Moderna Inc

NASDAQ:MRNA  
149.98
+7.13 (+4.99%)
5:10:32 PM EDT: $150.13 +0.15 (+0.10%)
Products

Moderna Says Co And Takeda Announce Plans To Transfer Marketing Authorization For Spikevax(Tm) Covid-19 Vaccine In Japan To Moderna

Published: 05/31/2022 07:52 GMT
Moderna Inc (MRNA) - Moderna Says Co and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(tm) Covid-19 Vaccine in Japan to Moderna.
Moderna-companies Concluded Mou That Takeda Will Continue to Provide Distribution Support for the Moderna Covid-19 Vaccines for a Transitional Period.
Moderna-co to Become Marketing Authorization Holder in Japan; Responsible for Import, Local Regulatory, Development, Activities for Spikevaxtm From Aug 1, 2022.